⭐️⭐️⭐️ The 9500th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry!
Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.
09.09.2025 00:43 — 👍 3 🔁 1 💬 0 📌 0
ALA/LaRDR/LA Lymphoma Breakfast Meeting
Please join us for breakfast during BLOOD 2025
📣 Register now for the hybrid Lymphoma Breakfast Meeting!
Join us online to hear updates on our work, presented alongside the Australian Lymphoma Alliance and Lymphoma Australia.
🥐☕ Breakfast will be provided for on-site attendees.
15.08.2025 06:30 — 👍 2 🔁 0 💬 0 📌 1
END‐OF‐TREATMENT PET/CT COMPLETE REMISSION IS HIGHLY PROGNOSTIC IN NODAL PERIPHERAL T‐CELL LYMPHOMA: AN AUSTRALASIAN‐CANADIAN COLLABORATIVE STUDY
Click on the article title to read more.
We're also showcasing our #18ICML posters:
-221, real-world data on end-of-treatment imaging #TCellLymphoma;
-390, Ki67 expression level in #FollicularLymphoma
See you June 18👋
@icmlugano.bsky.social @ericawood.bsky.social @elizahawkes.bsky.social
#LymphomaResearch #ClinicalResearch #Registry
18.06.2025 02:48 — 👍 1 🔁 1 💬 0 📌 0
LaRDR at EHA conference 2025!
Thanks to all who stopped by to chat with us at our #FollicularLymphoma #EHA2025 poster 👋
@hemasphere-journal.bsky.social @ericawood.bsky.social @elizahawkes.bsky.social
#LymphomaResearch #ClinicalResearch #Registry
17.06.2025 07:18 — 👍 2 🔁 1 💬 0 📌 0
DETERMINING THE PROGNOSTIC SIGNIFICANCE OF THE KI67 PROLIFERATION... by Eliza Chung
EHA Library; Chung E. Jun 14 2025; 4160959;
We're excited to meet you at our #EHA2025 poster PS1885 to talk about the study of Ki67 expression in Australasian #FollicularLymphoma patients.
See you Saturday, June 14 👋
@hemasphere-journal.bsky.social @ericawood.bsky.social @elizahawkes.bsky.social
#LymphomaResearch #ClinicalResearch #Registry
12.06.2025 05:00 — 👍 3 🔁 2 💬 0 📌 0
The Lymphoma and Related Diseases Registry enrolled the ⭐9000th⭐ participant on May 8, 2025!
We would like to express our sincere gratitude to all participants, participating sites and staff, principal investigators and industry partners for their continued support of the registry 🙌
08.05.2025 00:40 — 👍 2 🔁 2 💬 0 📌 0
YouTube video by Transfusion Research Unit
LaRDR Interview - Enabling research in a regional rural hospital
LaRDR provides #research 🔍 opportunities for #lymphoma & #CLL investigators and fellows in regional/rural hospitals🏥across Australia and New Zealand 🌏
Tune in to this interview to hear more from Dr Wight!
🎬 youtu.be/3csUYJsZkZs
06.05.2025 01:01 — 👍 1 🔁 0 💬 0 📌 0
YouTube video by Transfusion Research Unit
LaRDR Interview - Research experience from basic physician to haematology registrar
LaRDR supports early-career clinician-researchers by providing #research opportunities📊. They gain experience in manuscript writing ✍️ for publication and conference presentations.
Tune in to this interview to hear more from Dr Wang!
🎬 youtu.be/0rjytiYHhuY
01.05.2025 05:32 — 👍 1 🔁 1 💬 0 📌 0
YouTube video by Transfusion Research Unit
LaRDR Interview - Data contribution to international partnership
LaRDR partners with international researchers to conduct #lymphoma & #CLL #research and report on multi-centre data🌍
Tune in to this interview to hear more from Dr Viiala!
🎬 youtu.be/4iO__sHQr6A
29.04.2025 01:33 — 👍 1 🔁 0 💬 0 📌 0
YouTube video by Transfusion Research Unit
LaRDR Interview - Research experience as haematology trainee
LaRDR supports investigator-initiated studies utilising #registry data. Our collaborations facilitate #academic real-world #research ✏️
Tune in to this interview with Dr @baggydi.bsky.social!
🎬 youtu.be/vnOPIN-NOEg
24.04.2025 02:00 — 👍 3 🔁 1 💬 0 📌 0
YouTube video by Transfusion Research Unit
LaRDR Interview - Ensuring data quality for research
LaRDR collects high-quality data to conduct #lymphoma #research and monitor patient treatment outcomes.📚 We also provide ongoing data management training for the site study coordinators. 📝
Tune in to this interview with Dr @allibarraclough.bsky.social
🎬https://youtu.be/pbpHYVraHgA
16.04.2025 02:48 — 👍 2 🔁 0 💬 0 📌 0
YouTube video by Transfusion Research Unit
LaRDR Interview - Introduction to LaRDR
LaRDR is a national #registry with sites in Australia & New Zealand. We report on patient treatments & outcomes in #lymphoma care. We also support real-world #research.📄
Tune in to this interview with Prof Opat!
🎬 youtu.be/HRLTZEyITn0
14.04.2025 07:13 — 👍 1 🔁 0 💬 0 📌 2
The official open access journal of EHA - we publish basic, translational, & clinical heme research. Preliminary 2024 stats: #ImpactFactor = 14.6 (ranked #5).
#hematology #ScientificPublishing #BloodSky #HemeSky
👓 hemaspherejournal.com
19th International Conference on Malignant Lymphoma (June 15-19, 2027 - Lugano, Switzerland)
#19ICML
www.icml.ch
Plant scientist studying how climate change affects plant toxicity (#cyanide). Born 314ppm.
Interested in science, tech, plants. #MECFS ally #botanist 🌾🪴🧪🌱🌿💉
Views my own
We're an academic team of Research Data Specialists enabling data-intensive and data-informed research across disciplines
@unimelb www.unimelb.edu.au/mdap
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com
🌐 www.nature.com/natcancer/
📍New York, London, Berlin and Heidelberg
Professor @mdanderson.bsky.social , Lead of Lymphoma/Myeloma Service Line, Director of Clinical Research, Section Chief of Aggressive/Indolent Lymphomas, Opinions mine
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer. Appointments available: 1-877-632-6789
Basic and translational lymphoma researcher at BC Cancer. 🖥️🧬🩸Genomics and bioinformatics. 🚴🏼♀️🐕🇨🇦#bloodsky #hemesky #WomenInLymphoma
Lymphoma & partic CNSL, TCL & immunodeficiency
UCLH/UCL (no medical advice)
views my own
To better understand the causes of human cancer across Asia, thereby improve its detection, treatment and prevention. https://linktr.ee/csi_singapore?utm_source=linktree_profile_share<sid=eed1a145-1fad-49b9-8001-01c8f57309ca
🔬 We research and develop treatments for cancer, diseases of development and ageing, immune disorders and infections.
https://www.wehi.edu.au
ANZCA Clinical Trials Network is a world leader in delivering high quality trial evidence that translates into safe and effective practice in anaesthesia
Enabling the Australian research community and industry access to nationally significant digital research infrastructure, platforms, skills and data collections. Enabled by #NCRIS. Visit https://ardc.edu.au/
Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma
Peter MacCallum Cancer Centre – or Peter Mac – is a globally-connected leader in cancer treatment, care, research and education. Now in its 75th year of providing specialist cancer care for the Australian community.
This account is not actively posting follow us
@bloodjournals.hematology.org for the latest from Blood Journals Portfolio.
Lymphoma doctor and associate professor of Haematology at Oxford University Hospitals, UK. Husband, father, Christian.
Haematologist, lymphoma specialist, and Lead of Aggressive Lymphoma at Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Cabrini in Melbourne, Australia. Phase 1 trials, drug development, immunotherapies, CAR-T cell therapy.
Assoc Professor. Biostats. HSR. HemeOnc. CTS. Tufts.
